Sentences with phrase «tb vaccine research»

About Blog Innovative and high quality TB Vaccine research in Africa to impact the Global epidemic.

Many thanks to all of the partners, staff, donors and stakeholders who helped further TB vaccine research in 2016.

But Aeras will continue to fight for progress by learning as much as we can from our ongoing trials and research; by sharing scientific gains, building strong partnerships, and making sure that the world hears our call for increased and essential investment in TB vaccine research and development; and by leading the push for innovation, in the lab and beyond.

We work through partnerships in both the public and private sectors, with individuals, research organizations, academic institutions, funders, policymakers and others around the world to make progress in TB vaccine research.

Aeras will highlight the progress being made in TB vaccine research at the 5th Global Forum on TB Vaccines in New Delhi, India, February 20 - 23, 2018.

Not exact matches

Orme and his research team in Fort Collins investigated whether the existing vaccine for TB, which goes by the acronym BCG (bacille Calmette - Guerin), worked equally well against different clinical strains of tuberculosis.

«Taken together, these two studies suggest that the new scalable vaccine formulation is likely to prove as effective as the original formulation — which would make it the first protective TB vaccine in humans since BCG, which was introduced almost a century ago,» said Professor Ajit Lalvani, Director of the Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London and a member of the DAR - 901 development team.

The results are encouraging, says immunologist Douglas Lowrie of the National Institute for Medical Research in the United Kingdom, who has worked on DNA vaccines and recently co-developed a fast test for TB.

Nanotheraputics for Antibiotic Resistent Emerging Bacterial pathogens (NAREB) European Research Infrastructures for Poverty Related Diseases (EURIPED) Biomarkers for enhanced vaccines immunosafety (BioVacSafe) European network of vaccine research and development TRANSVAC Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development (TBResearch Infrastructures for Poverty Related Diseases (EURIPED) Biomarkers for enhanced vaccines immunosafety (BioVacSafe) European network of vaccine research and development TRANSVAC Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development (TBresearch and development TRANSVAC Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development (TBVAC2020)

LSHTM has active cross disciplinary research centres for vaccines with over 100 personnel, and has the largest grouping of researchers working on TB in Europe.

The research of the Department of Parasitology is focused on developing vaccines and drugs against malaria and TB, using non-human primate models.

With particular emphasis on the increased mathematical demands of the 2015 AQA, OCR and Pearson Edexcel teaching specifications, this multimedia data handling teaching resource provides an overview of TB and drug - resistant TB (DR - TB) including risk factors of developing TB, available vaccines and treatments, current research and development of both drugs and diagnostic tools.